A detailed history of Capital Impact Advisors, LLC transactions in Schrodinger, Inc. stock. As of the latest transaction made, Capital Impact Advisors, LLC holds 12,827 shares of SDGR stock, worth $223,702. This represents 0.71% of its overall portfolio holdings.

Number of Shares
12,827
Previous 15,420 16.82%
Holding current value
$223,702
Previous $416,000 40.38%
% of portfolio
0.71%
Previous 0.55%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 16, 2024

SELL
$18.65 - $28.5 $48,359 - $73,900
-2,593 Reduced 16.82%
12,827 $248,000
Q1 2024

May 15, 2024

SELL
$24.74 - $35.13 $208,112 - $295,513
-8,412 Reduced 35.3%
15,420 $416,000
Q4 2023

Feb 14, 2024

BUY
$21.62 - $37.21 $44,883 - $77,247
2,076 Added 9.54%
23,832 $853,000
Q3 2023

Nov 14, 2023

BUY
$27.34 - $55.37 $134,704 - $272,807
4,927 Added 29.28%
21,756 $615,000
Q2 2023

Aug 14, 2023

BUY
$26.1 - $49.92 $25,082 - $47,973
961 Added 6.06%
16,829 $840,000
Q1 2023

May 23, 2023

BUY
$18.09 - $27.61 $16,299 - $24,876
901 Added 6.02%
15,868 $417,000
Q4 2022

Feb 14, 2023

BUY
$16.24 - $26.38 $103,448 - $168,040
6,370 Added 74.1%
14,967 $279,000
Q3 2022

Nov 21, 2022

BUY
$23.95 - $34.71 $3,281 - $4,755
137 Added 1.62%
8,597 $164,000
Q2 2022

Aug 15, 2022

BUY
$21.39 - $35.9 $180,959 - $303,714
8,460 New
8,460 $223,000
Q1 2021

May 18, 2021

SELL
$64.61 - $113.09 $1.62 Million - $2.83 Million
-25,000 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$48.06 - $84.4 $1.2 Million - $2.11 Million
25,000 New
25,000 $1.98 Million

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.08B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.